Ads
related to: myasthenic syndrome lems- Patient Access & Support
Learn About Personalized Support
For Your Patients.
- How FIRDAPSE Works
Learn About FIRDAPSE As A Treatment
And How It Works In The Body.
- Safety & Tolerability
View Common Side Effects And
Safety Information.
- Contact Catalyst
Get In Touch With A FIRDAPSE
Team Member.
- Sign Up For Updates
Register To Receive All Updates
On FIRDAPSE.
- Efficacy
View Clinical Trial Results Of
FIRDAPSE Compared With Placebo.
- Patient Access & Support
Search results
Catalyst Pharmaceuticals (CPRX) Rallies 80.69% YTD: Here's Why
Zacks via Yahoo Finance· 2 years agoCatalyst Pharmaceuticals CPRX stock has skyrocketed 80.6% in the year-to-date period against the...
Catalyst Pharmaceuticals' CEO Wants In On The Biotech Buying Spree
Investor's Business Daily· 2 years agoCatalyst Pharmaceuticals Chief Executive Patrick McEnany has one thing to say to CPRX stock...
Catalyst Pharmaceuticals: An Attractive Biopharma Bet
GuruFocus.com via Yahoo Finance· 4 months agoCatalyst Pharmaceuticals Inc. (NASDAQ:CPRX) is an attractive biopharma stock to own, given the niche...
Here's How Much You'd Have If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago
Zacks via Yahoo Finance· 2 years agoHow much a stock's price changes over time is a significant driver for most investors. Not only can...
Catalyst (CPRX) Q4 Earnings & Sales Beat Estimates, Stock Up
Zacks via Yahoo Finance· 3 months agoCatalyst Pharmaceuticals, Inc. CPRX reported adjusted diluted earnings of 53 cents per share for the...
Catalyst (CPRX) Seeks to Increase Maximum Daily Dose for Firdapse
Zacks via Yahoo Finance· 8 months agoThe FDA accepts Catalyst's (CPRX) sNDA to increase the indicated maximum daily dosage of Firdapse 10...
Pharmaceutical Stock Clears Entry Following Two Prior Gap-Ups
Investor's Business Daily· 2 years agoPharmaceutical stock Catalyst Pharmaceuticals cleared yet another pattern. Shares are trading above...
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
Zacks via Yahoo Finance· 1 month agoCatalyst Pharmaceuticals, Inc. CPRX reported adjusted earnings of 38 cents per share for the first...
Catalyst Pharmaceuticals (CPRX) Q2 Earnings Top, Revenues Up
Zacks via Yahoo Finance· 2 years agoCatalyst Pharmaceuticals, Inc. CPRX reported earnings of 20 cents per share in the second quarter of...
These 3 Stocks Are Winning the Bear Market -- Here's How
Motley Fool· 2 years agoThe market may be down 23% this year, but that hasn't stopped a trio of drug companies from powering...
Ads
related to: myasthenic syndrome lems
